The tests will be conducted following the standard guidelines dictated by the European Medicine Agency (EMA/CHMP/594085/2015) and the procedures described by the European Committee on Antimicrobial Susceptibility Testing (EUCAST). Parallel to the efficacy studies, Renolab is further expanding the certification for cell and molecular biology studies including genotypic characterization and genetic stability.
Renolab aims to:
- Provide GLP-based services for the pharmaceutical industry
- Enhance the importance of GLP-based tests in the development of studies concerning human health
Get in touch with our experts at Renolab to learn more.
About Renolab s.r.l.
Renolab is an analysis laboratory with in-depth experience in performing analyses in accordance with GLP. The laboratory complies with the Italian Ministry of Health directives for chemical and physical characterizations, and for residue studies on agrochemicals, biocides, cosmetics, drugs, additives and other industrial chemical products. Renolab’s microbiological studies also comply with the OECD principles, European directives and Italian legislation.
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 65 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Tentamus Group
An der Industriebahn 5
13088 Berlin, Germany
www.tentamus.com
Tentamus Group GmbH
An der Industriebahn 5
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://tentamus.com
CEO Renolab GLP
Telefon: +39 347 630 16 74
E-Mail: rita.resca@renolab-glp.com
